Providence Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18
| Closed | -$1.22K | – | 328 |
|
|
2022
Q4 | $1.22K | Hold |
18
| – | – | ﹤0.01% | 265 |
|
|
2022
Q3 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 302 |
|
|
2022
Q1 | – | Sell |
-1,432
| Closed | -$80K | – | 499 |
|
|
2021
Q4 | $80K | Sell |
1,432
-3,698
| -72% | -$207K | 0.02% | 134 |
|
|
2021
Q3 | $246K | Hold |
5,130
| – | – | 0.08% | 103 |
|
|
2021
Q2 | $215K | Sell |
5,130
-720
| -12% | -$30.2K | 0.07% | 105 |
|
|
2021
Q1 | $197K | Hold |
5,850
| – | – | 0.07% | 101 |
|
|
2020
Q4 | $204K | Buy |
+5,850
| New | +$204K | 0.08% | 97 |
|
|
2019
Q1 | – | Sell |
-1,080
| Closed | -$25K | – | 321 |
|
|
2018
Q4 | $25K | Hold |
1,080
| – | – | 0.02% | 154 |
|
|
2018
Q3 | $25K | Hold |
1,080
| – | – | 0.02% | 160 |
|
|
2018
Q2 | $25K | Hold |
1,080
| – | – | 0.02% | 148 |
|
|
2018
Q1 | $27K | Sell |
1,080
-212
| -16% | -$5.3K | 0.02% | 139 |
|
|
2017
Q4 | $35K | Buy |
+1,292
| New | +$35K | 0.03% | 130 |
|